2. All‐cause Mortality.

Study	Number of participants randomised	Number of participants analysed	Prophylactic Granulocytes	Control
Mortality at up to 21 days
Clift 1978	86	69	0/29	1/40
Gomez‐Villagran 1984	35	35	2/19	6/16
Mortality at up to 30 days
Ford 1982	49	24	3/13	2/11
Mannoni 1979	44	44 in 50 episodes of aplasia	0/20	4/26
Oza 2006	151	151	2/53	5/98
Schiffer 1979	22	18	0/9	2/9
Strauss 1981	102	102	12/54	6/48
Winston 1980	38	38	13/19	13/19
Mortality at up to 100 days
Petersen 1987	134	112	21/67	11/45
Mortality over 100 days
Sutton 1982	67	64	19/28	25/36